Page last updated: 2024-10-30

mesalamine and Infections, Legionella pneumophila

mesalamine has been researched along with Infections, Legionella pneumophila in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"After 2 weeks' treatment with sulfasalazine (SASP) and mesalazine enema, a 32-year-old female with recently diagnosed ulcerative colitis developed bilateral pulmonary infiltrates with peripheral eosinophilia."3.70[Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia]. ( Avar, S; Bielecki, JW; Joss, R, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bielecki, JW1
Avar, S1
Joss, R1

Other Studies

1 other study available for mesalamine and Infections, Legionella pneumophila

ArticleYear
[Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia].
    Schweizerische medizinische Wochenschrift, 2000, Jul-25, Volume: 130, Issue:29-30

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Enema;

2000